Who has invested in KingstronBio?

Guangfa Qianhe, lu xiaobao, panglin investment are named among the investors backing KingstronBio.

KingstronBio Funding: $66M Raised, Series C (2021)

KingstronBio funding overview

KingstronBio is based in Beijing, China. KingstronBio has raised $66M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in November 2021. The round record for KingstronBio runs through 2021; nothing later has been disclosed. Investors on record include Guangfa Qianhe, lu xiaobao, panglin investment. 3 distinct backers are named across the disclosed rounds.

KingstronBio at a glance

Total raised: $66M
Latest round: Series C
Latest round date: November 2021
Headquarters: Beijing, China
Notable investors: Guangfa Qianhe, lu xiaobao, panglin investment

Frequently asked about KingstronBio funding

How much has KingstronBio raised?: KingstronBio has raised $66M in total disclosed funding across the rounds on record.
Who has invested in KingstronBio?: Guangfa Qianhe, lu xiaobao, panglin investment are named among the investors backing KingstronBio.
What was the latest KingstronBio funding round?: The most recent disclosed round is a Series C, announced in November 2021.
Where is KingstronBio based?: KingstronBio is based in Beijing, China.
When did KingstronBio last raise?: The last disclosed KingstronBio round closed in November 2021 at Series C.

Round data for KingstronBio is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Beijing and backer lists below.

KingstronBio Funding: $66M Raised, Series C (2021)

KingstronBio funding overview

KingstronBio at a glance

Frequently asked about KingstronBio funding

Companies related to KingstronBio (19)

Browse related funding lists (5)